News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
41,568 Results
Type
Article (2590)
Company Profile (45)
Press Release (38932)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (14315)
Career Advice (78)
Deals (2131)
Drug Delivery (9)
Drug Development (4576)
Employer Resources (10)
FDA (561)
Job Trends (868)
News (21015)
Policy (1169)
Tag
Academia (149)
Accelerated approval (1)
Allergies (7)
Alliances (3552)
ALS (6)
Alzheimer's disease (61)
Antibody-drug conjugate (ADC) (32)
Approvals (574)
Artificial intelligence (31)
Autoimmune disease (8)
Automation (2)
Bankruptcy (12)
Best Places to Work (570)
BIOSECURE Act (2)
Biosimilars (16)
Biotechnology (29)
Bladder cancer (10)
Brain cancer (8)
Breast cancer (80)
Cancer (467)
Cardiovascular disease (10)
Career advice (66)
Career pathing (1)
CAR-T (31)
CDC (1)
Cell therapy (87)
Cervical cancer (3)
Clinical research (3896)
Collaboration (208)
Company closure (2)
Compensation (104)
COVID-19 (185)
CRISPR (11)
C-suite (112)
Cystic fibrosis (7)
Data (491)
Denatured (6)
Depression (11)
Diabetes (17)
Diagnostics (524)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (37)
Drug pricing (10)
Duchenne muscular dystrophy (40)
Earnings (4549)
Editorial (5)
Employer branding (1)
Employer resources (8)
Events (6580)
Executive appointments (135)
FDA (734)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (171)
Gene editing (32)
Generative AI (1)
Gene therapy (56)
GLP-1 (63)
Government (164)
Guidances (25)
Healthcare (755)
HIV (1)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (34)
Immuno-oncology (14)
Indications (6)
Infectious disease (197)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (27)
Interviews (7)
IPO (1014)
IRA (7)
Job creations (293)
Job search strategy (62)
JPM (4)
Kidney cancer (6)
Labor market (11)
Layoffs (51)
Leadership (3)
Legal (218)
Liver cancer (7)
Longevity (1)
Lung cancer (58)
Lymphoma (27)
Machine learning (3)
Management (4)
Manufacturing (53)
MASH (14)
Medical device (327)
Medtech (328)
Mergers & acquisitions (1232)
Metabolic disorders (72)
Multiple sclerosis (22)
Neurodegenerative disease (27)
Neuropsychiatric disorders (10)
Neuroscience (166)
NextGen: Class of 2026 (358)
Non-profit (168)
Now hiring (11)
Obesity (32)
Opinion (17)
Ovarian cancer (19)
Pain (24)
Pancreatic cancer (24)
Parkinson's disease (11)
Partnered (4)
Patents (56)
Patient recruitment (30)
Peanut (1)
People (5902)
Pharmaceutical (5)
Phase 1 (1604)
Phase 2 (1821)
Phase 3 (1150)
Pipeline (408)
Policy (16)
Postmarket research (41)
Preclinical (648)
Press Release (2)
Prostate cancer (14)
Psychedelics (3)
Radiopharmaceuticals (14)
Rare diseases (65)
Real estate (425)
Recruiting (5)
Regulatory (1053)
Reports (7)
Research institute (156)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (5)
RSV (1)
Schizophrenia (16)
Series A (46)
Series B (20)
Service/supplier (2)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (498)
Stomach cancer (2)
Supply chain (4)
Tariffs (2)
The Weekly (3)
Vaccines (52)
Venture capital (15)
Weight loss (21)
Women's health (10)
Worklife (1)
Date
Today (1)
Last 7 days (43)
Last 30 days (175)
Last 365 days (2540)
2026 (221)
2025 (2567)
2024 (2780)
2023 (3011)
2022 (3908)
2021 (4215)
2020 (3609)
2019 (2137)
2018 (1637)
2017 (1894)
2016 (1697)
2015 (1889)
2014 (1397)
2013 (1209)
2012 (1406)
2011 (1351)
2010 (1193)
Location
Africa (44)
Alabama (3)
Arizona (19)
Asia (2126)
Australia (317)
California (1658)
Canada (248)
China (86)
Colorado (56)
Connecticut (27)
Delaware (9)
Europe (4233)
Florida (70)
Georgia (11)
Hawaii (2)
Idaho (3)
Illinois (25)
India (2)
Indiana (66)
Japan (26)
Kansas (14)
Kentucky (3)
Maryland (49)
Massachusetts (577)
Michigan (14)
Minnesota (25)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (172)
New York (86)
North Carolina (142)
Northern California (825)
Ohio (46)
Oklahoma (2)
Oregon (6)
Pennsylvania (114)
Puerto Rico (1)
Rhode Island (2)
South America (43)
South Carolina (1)
Southern California (662)
Tennessee (4)
Texas (158)
United States (3382)
Utah (5)
Virginia (11)
Washington D.C. (3)
Washington State (101)
West Virginia (1)
Wisconsin (14)
41,568 Results for "seer biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Seer to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
February 6, 2026
·
1 min read
Press Releases
Seer Reports Third Quarter 2025 Financial Results
November 6, 2025
·
7 min read
Press Releases
Seer to Participate in Upcoming November 2025 Investor Conferences
October 30, 2025
·
1 min read
Press Releases
Seer to Report Third Quarter 2025 Financial Results on November 6, 2025
October 17, 2025
·
1 min read
Press Releases
RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
October 16, 2025
·
6 min read
Press Releases
Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
August 26, 2025
·
1 min read
Press Releases
Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics (ASHG) 2025
October 10, 2025
·
3 min read
Press Releases
Seer to Participate in the Canaccord Genuity 45th Annual Growth Conference
July 31, 2025
·
1 min read
Press Releases
Seer Reports Second Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook
August 7, 2025
·
7 min read
Press Releases
Seer to Report First Quarter 2025 Financial Results on May 13, 2025
April 25, 2025
·
1 min read
1 of 4,157
Next
